Browse by UCL people
Group by: Type | Date
Number of items: 37.
Article
Bishop, CA;
Ricotti, V;
Sinclair, CDJ;
Evans, MRB;
Butler, JW;
Morrow, JM;
Hanna, MG;
... Janiczek, RL; + view all
(2018)
Semi-Automated Analysis of Diaphragmatic Motion with Dynamic Magnetic Resonance Imaging in Healthy Controls and Non-Ambulant Subjects with Duchenne Muscular Dystrophy.
Frontiers in Neurology
, 9
, Article 9. 10.3389/fneur.2018.00009.
|
 |
|
Bugiardini, E;
Khan, A;
Phadke, R;
Lynch, DS;
Cortese, A;
Feng, L;
Gang, Q;
... Hanna, MG; + view all
(2019)
Genetic and phenotypic characterisation of inherited myopathies in a tertiary neuromuscular centre.
Neuromuscular Disorders
, 29
(10)
pp. 747-757.
10.1016/j.nmd.2019.08.003.
|
|
Bugiardini, E;
Morrow, JM;
Shah, S;
Woods, CL;
Lynch, DS;
Pitmann, AM;
Reilly, MM;
... Yousry, TA; + view all
(2018)
The Diagnostic Value of MRI Pattern Recognition in Distal Myopathies.
Frontiers in Neurology
, 9
, Article 456. 10.3389/fneur.2018.00456.
|
|
|
Doherty, Carolynne M;
Howard, Paige;
O'Donnell, Luke F;
Zuccarino, Riccardo;
Wastling, Stephen;
Milev, Evelin;
Banks, Tina;
... Reilly, Mary M; + view all
(2024)
Quantitative Foot Muscle Magnetic Resonance Imaging Reliably Measures Disease Progression in Children and Adolescents with Charcot–Marie–Tooth Disease Type 1A.
Annals of Neurology
10.1002/ana.26934.
(In press).
|
|
Elmansy, Mostafa;
Morrow, Jasper M;
Shah, Sachit;
Fischmann, Arne;
Wastling, Stephen;
Reilly, Mary M;
Hanna, Michael G;
... Yousry, Tarek A; + view all
(2022)
Evidence of nerve hypertrophy in patients with inclusion body myositis on lower limb MRI.
Muscle & Nerve
, 66
(6)
pp. 744-749.
10.1002/mus.27728.
|
 |
|
Guja, A;
Morrow Jasper, M;
Adnan, M;
Roxana, G;
Roberta, B;
Eugenio, M;
Reilly, MR;
... Yousry, TA; + view all
(2022)
Muscle "islands": an MRI signature distinguishing neurogenic from myopathic causes of early onset distal weakness.
Neuromuscular Disorders
, 32
(2)
pp. 142-149.
10.1016/j.nmd.2021.11.003.
|
|
Kanber, B;
Morrow, JM;
Klickovic, U;
Wastling, S;
Shah, S;
Fratta, P;
McDowell, AR;
... Thornton, JS; + view all
(2021)
Musclesense: a Trained, Artificial Neural Network for the Anatomical Segmentation of Lower Limb Magnetic Resonance Images in Neuromuscular Diseases.
Neuroinformatics
, 19
pp. 379-383.
10.1007/s12021-020-09485-5.
|
|
Khoo, A;
McLoughlin, B;
Cheema, S;
Weil, RS;
Lambert, C;
Manji, H;
Zandi, MS;
(2020)
Postinfectious brainstem encephalitis associated with SARS-CoV-2.
Journal of Neurology, Neurosurgery & Psychiatry
, 91
(9)
pp. 1013-1014.
10.1136/jnnp-2020-323816.
|
|
Klickovic, U;
Zampedri, L;
Sinclair, CDJ;
Wastling, SJ;
Trimmel, K;
Howard, RS;
Malaspina, A;
... Fratta, P; + view all
(2019)
Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity.
Neurology
10.1212/WNL.0000000000008009.
(In press).
|
|
|
Laurá, M;
Singh, D;
Ramdharry, G;
Morrow, J;
Skorupinska, M;
Pareyson, D;
Burns, J;
... Reilly, MM; + view all
(2018)
Prevalence and orthopedic management of foot and ankle deformities in Charcot-Marie-Tooth disease.
Muscle & Nerve
, 57
(2)
pp. 255-259.
10.1002/mus.25724.
|
|
|
Machado, PM;
Ahmed, M;
Brady, S;
Gang, Q;
Healy, E;
Morrow, JM;
Wallace, AC;
... Hanna, MG; + view all
(2014)
Ongoing developments in sporadic inclusion body myositis.
Curr Rheumatol Rep
, 16
(12)
, Article 477. 10.1007/s11926-014-0477-9.
|
|
|
Morrow, JM;
Evans, MRB;
Grider, T;
Sinclair, CDJ;
Thedens, D;
Shah, S;
Yousry, TA;
... Reilly, MM; + view all
(2018)
Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A.
Neurology
10.1212/WNL.0000000000006214.
|
|
|
Morrow, JM;
Matthews, E;
Raja Rayan, DL;
Fischmann, A;
Sinclair, CD;
Reilly, MM;
Thornton, JS;
... Yousry, TA; + view all
(2013)
Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias.
Neuromuscular Disorders
, 23
(8)
pp. 637-646.
10.1016/j.nmd.2013.05.001.
|
|
|
Morrow, JM;
Sinclair, CD;
Fischmann, A;
Machado, PM;
Reilly, MM;
Yousry, TA;
Thornton, JS;
(2016)
MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.
Lancet Neurology
, 15
(1)
pp. 65-77.
10.1016/S1474-4422(15)00242-2.
|
|
Morrow, JM;
Sinclair, CD;
Fischmann, A;
Reilly, MM;
Hanna, MG;
Yousry, TA;
Thornton, JS;
(2014)
Reproducibility, and age, body-weight and gender dependency of candidate skeletal muscle MRI outcome measures in healthy volunteers.
European Radiology
, 24
(7)
pp. 1610-1620.
10.1007/s00330-014-3145-6.
|
|
|
Murphy, AP;
Morrow, J;
Dahlqvist, JR;
Stojkovic, T;
Willis, TA;
Sinclair, CDJ;
Wastling, S;
... Straub, V; + view all
(2019)
Natural history of limb girdle muscular dystrophy R9 over 6 years: searching for trial endpoints.
Annals of Clinical and Translational Neurology
, 6
(6)
pp. 1033-1045.
10.1002/acn3.774.
|
|
|
O'Donnell, Luke F;
Pipis, Menelaos;
Thornton, John S;
Kanber, Baris;
Wastling, Stephen;
McDowell, Amy;
Zafeiropoulos, Nick;
... Reilly, Mary M; + view all
(2023)
Quantitative MRI outcome measures in CMT1A using automated lower limb muscle segmentation.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2023-332454.
|
|
Paterson, RW;
Brown, RL;
Benjamin, L;
Nortley, R;
Wiethoff, S;
Bharucha, T;
Jayaseelan, DL;
... UCL Queen Square National Hospital for Neurology and Neurosurger; + view all
(2020)
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.
Brain
10.1093/brain/awaa240.
(In press).
|
|
|
Pipis, M;
Feely, SME;
Polke, JM;
Skorupinska, M;
Perez, L;
Shy, RR;
Laura, M;
... Inherited Neuropathies Consortium - Rare Disease Clinical Resear; + view all
(2021)
Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study.
Brain
10.1093/brain/awaa323.
(In press).
|
|
|
Pitceathly, RD;
Morrow, JM;
Sinclair, CD;
Woodward, C;
Sweeney, MG;
Rahman, S;
Plant, GT;
... Thornton, JS; + view all
(2015)
Extra-ocular muscle MRI in genetically-defined mitochondrial disease.
European Radiology
, 26
pp. 130-137.
10.1007/s00330-015-3801-5.
|
|
Ramdharry, G;
Morrow, J;
Hudgens, S;
Skorupinska, I;
Gwathmey, K;
Currence, M;
Herbelin, L;
... Sadjadi, R; + view all
(2019)
Investigation of the psychometric properties of the Inclusion Body Myositis Functional Rating Scale using Rasch analysis.
Muscle & Nerve
, 60
(2)
pp. 161-168.
10.1002/mus.26521.
|
|
Ribeiro, A;
Suetterlin, KJ;
Skorupinska, I;
Tan, SV;
Morrow, JM;
Matthews, E;
Hanna, MG;
(2021)
The long exercise test as a functional marker of periodic paralysis.
Muscle & Nerve
10.1002/mus.27465.
(In press).
|
|
|
Ricotti, V;
Evans, MRB;
Sinclair, CDJ;
Butler, JW;
Ridout, DA;
Hogrel, J-Y;
Emira, A;
... Thornton, JS; + view all
(2016)
Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
PLOS ONE
, 11
(9)
10.1371/journal.pone.0162542.
|
|
|
Rossor, AM;
Morrow, JM;
Polke, JM;
Murphy, SM;
Houlden, H;
INC-RDCRC;
Laura, M;
... Reilly, MM; + view all
(2016)
Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene.
Neuromuscular Disorders
, 27
(1)
pp. 50-56.
10.1016/j.nmd.2016.10.001.
|
|
|
Salam, Sharfaraz;
Morrow, Jasper M;
Howard, Robin;
Miller, James AL;
Quinlivan, Ros M;
Machado, Pedro M;
(2023)
Two emerging phenotypes of atypical inclusion body myositis: illustrative cases.
Clinical and Experimental Rheumatology
, 41
(2)
pp. 340-347.
10.55563/clinexprheumatol/jq7zxd.
|
|
Salam, Sharfaraz;
Morrow, Jasper M;
Shah, Sachit;
Hanna, Michael G;
Dimachkie, Mazen M;
Machado, Pedro M;
(2025)
Imaging evaluation of the upper limbs in inclusion body myositis: an unmet need.
Clinical and Experimental Rheumatology
, 43
(2)
pp. 372-378.
10.55563/clinexprheumatol/q7ozm2.
|
|
|
Scalco, RS;
Morrow, JM;
Booth, S;
Chatfield, S;
Godfrey, R;
Quinlivan, R;
(2017)
Misdiagnosis is an important factor for diagnostic delay in McArdle disease.
Neuromuscular Disorders
, 27
(9)
pp. 852-855.
10.1016/j.nmd.2017.04.013.
|
|
Scalco, RS;
Skorupinska, I;
Blochet, C;
Habib, M;
Matthews, E;
Morrow, J;
Hanna, M;
(2016)
Bumetanide in hypokalaemic periodic paralysis: a randomised, double-blind, placebo controlled phase II clinical trial with a crossover design.
Neuromuscular Disorders
, 26
(S2)
, Article P.373. 10.1016/j.nmd.2016.06.402.
|
|
Sinclair, CD;
Morrow, JM;
Janiczek, RL;
Evans, MR;
Rawah, E;
Shah, S;
Hanna, MG;
... Thornton, JS; + view all
(2016)
Stability and sensitivity of water T2 obtained with IDEAL-CPMG in healthy and fat-infiltrated skeletal muscle.
NMR in Biomedicine
, 29
(12)
pp. 1800-1812.
10.1002/nbm.3654.
|
|
Varatharaj, A;
Thomas, N;
Ellul, MA;
Davies, NWS;
Pollak, TA;
Tenorio, EL;
Sultan, M;
... CoroNerve Study Group, .; + view all
(2020)
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.
The Lancet Psychiatry
, 7
(10)
pp. 875-882.
10.1016/S2215-0366(20)30287-X.
|
|
|
Vishnu, Venugopalan Y;
Lemmers, Richard JLF;
Reyaz, Alisha;
Mishra, Rinkle;
Ahmad, Tanveer;
van der Vliet, Patrick J;
Kretkiewicz, Marcelina M;
... Srivastava, MV Padma; + view all
(2024)
The first genetically confirmed cohort of Facioscapulohumeral Muscular Dystrophy from Northern India.
european journal of human genetics
10.1038/s41431-024-01577-z.
(In press).
|
|
|
Vivekanandam, V;
Bugiardini, E;
Merve, A;
Parton, M;
Morrow, JM;
Hanna, MG;
Machado, PM;
(2020)
Differential Diagnoses of Inclusion Body Myositis.
Neurologic Clinics
, 38
(3)
pp. 697-710.
10.1016/j.ncl.2020.03.014.
|
|
Willis, TA;
Hollingsworth, KG;
Coombs, A;
Sveen, ML;
Andersen, S;
Stojkovic, T;
Eagle, M;
... Straub, V; + view all
(2013)
Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study.
PLoS One
, 8
(8)
, Article e70993. 10.1371/journal.pone.0070993.
|
|
Proceedings paper
|
de Visser, M;
Carlier, P;
Vencovský, J;
Kubínová, K;
Preusse, C;
Albayda, J;
Allenbach, Y;
... Verhamme, C; + view all
(2023)
255th ENMC workshop: Muscle imaging in idiopathic inflammatory myopathies. 15th January, 16th January and 22nd January 2021 – virtual meeting and hybrid meeting on 9th and 19th September 2022 in Hoofddorp, The Netherlands.
In:
Neuromuscular Disorders: Volume 33, Issue 10.
(pp. pp. 800-816).
Elsevier: Amsterdam, Netherlands.
|
Conference item
|
Scalco, RS;
Morrow, J;
Manole, A;
Skorupinska, I;
Bellin, A;
Ricciardi, F;
Matthews, E;
... Fialho, D; + view all
(2018)
RCT of Bumetanide in Hypokalaemic Periodic Paralysis (HypoPP) using abductor digiti minimi compound muscle action potential (CMAP) as an objective outcome measure.
Presented at: 11th Annual UK Neuromuscular Translational Research Conference, Cambridge.
|
|
Scalco, RS;
Morrow, J;
Skorupinska, I;
Manole, AA;
Bellin, A;
Ricciardi, F;
Matthews, E;
... Fialho, D; + view all
(2018)
EPR2165: RCT assessing 2mg bumetanide as a therapeutic agent for a focal attack of weakness in Hypokalaemic Periodic Paralysis (HypoPP).
Presented at: 4th Congress of the European Academy of Neurology, Lisbon, Portugal.
|
Thesis
|
Morrow, JM;
(2017)
Development of quantitative MRI as an outcome measure in Charcot-Marie-Tooth disease and inclusion body myositis.
Doctoral thesis , UCL (University College London).
|
|
